Evidence map›Paper›PMID 41051717›Full record

ArticleInternational journal of clinical pharmacy2026

Disparities associated with race and ethnicity in pain management: a scoping review.

D Patterson, C McGuinness, S Dunne, C Ibechukwu Kane, L R Wogu, J Hayden, J Strawbridge

Abstract readScoping Review
In one paragraph

Article in International journal of clinical pharmacy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

D PattersonSchool of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland. diane.patterson@tus.ie.ORCID http://orcid.org/0000-0003-3828-4830
C McGuinnessSchool of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
S DunneDepartment of General Practice, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
C Ibechukwu KanePatient Partner, Cork, Ireland.
L R WoguPatient Partner, Sickle Cell and Thalassemia, Dublin, Ireland.
J HaydenSchool of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.ORCID http://orcid.org/0000-0003-3344-6888
J StrawbridgeSchool of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.ORCID http://orcid.org/0000-0003-1876-8790

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHealth inequalities can occur where there are differences in how people are treated with respect to their race and ethnicity. Disparities and systemic inequities in healthcare have led to negative outcomes. Pain management is an area where there are perceived health inequalities. Medicines optimisation is a framework for healthcare provider interventions under four principles to ensure that medicines are used safely and effectively, producing the best possible outcomes for patients. Using this framework allows a systematic and theory-informed identification of areas of care at risk of disparities.

aimThe aim was to assess disparities associated with race and ethnicity in pain management, mapped to the medicines optimisation framework.

methodElectronic databases CINAHL, Ovid and Medline were searched from 2012 to 2025. Studies involving pain management, medicine optimisation, ethnicity, ethnic minorities and race were included. Two reviewers independently screened titles, abstracts and full texts. Data were extracted on evidence relating to the application of the four principles of medicines optimisation, and for the presence or absence of disparities in pain management overall.

resultsOne hundred and eighteen studies were identified that met the inclusion criteria. Eighty-nine (75%) identified pain management disparities in respect to race and ethnicity, with the majority of disparities related to medicine optimisation principle 2 (evidenced based medicine). Disparities identified were discrepancies in the reporting of pain scores, time to pain and pain assessment and discrepancies in the receipt of opioids across all races. Other disparities were, inconsistencies with prescriptions issued at discharge or outpatients, patients' dissatisfaction with pain management. There were less disparities observed in studies that involved children, when managing surgical pain and pain in palliative care and when protocols were used in the management of pain.

conclusionDisparities in pain management associated with patient race and ethnicity are prevalent have decreased over the past decade. Healthcare professionals should seek to understand the patient experience and incorporate protocols/guidelines into their care to promote evidence-based medicine. Further research in wider geographies is required, particularly in medication safety and incorporating medicines optimisation into routine care.

Indexed as

EthnicityHealthcare DisparitiesPainPain ManagementRacial GroupsHumansEthnic and racial minoritiesEthnicityHealth inequalitiesPain managementRace

Identifiers

PMID41051717
PMCPMC12992414

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.